You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2024

AbstractFullPdf
Nov 2020333028
Dec 202066011
Jan 20213503
Feb 20218308
Mar 20213906
Apr 20214206
May 2021305
Jun 2021005
Jul 2021009
Aug 2021005
Sep 2021003
Oct 202132015
Nov 202118017
Dec 2021800
Jan 20221801
Feb 20221403
Mar 20221802
Apr 20223805
May 20223202
Jun 20222601
Jul 20221401
Aug 20222604
Sep 2022800
Oct 20221402
Nov 20222603
Dec 2022600
Jan 20233001
Feb 20232801
Mar 20231000
Apr 20231602
May 20231000
Jun 2023600
Jul 20231202
Aug 2023802
Sep 20231200
Oct 20231202
Nov 20231401
Dec 20233404
Jan 20244801
Feb 2024800
Mar 20241202
Apr 20241204
May 20242405
Jun 20242602
Jul 20242202
Aug 20241400
Sep 20242003
Total12770179